Tumor necrosis factor-α and tumor necrosis factor receptor I, II levels in patients with severe burns

Burns

Volumn 26, Issue 3, 2000, Pages 239-244

  Yamada, Y ^a   Endo, S ^a   Inada, K ^a   Nakae, H ^a   Nasu, W ^a   Taniguchi, S ^a   Ishikura, H ^b   Tanaka, T ^b   Wakabayashi, G ^c   Taki, K ^d   Sato, S ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SAGA UNIVERSITY   (Japan)

Author keywords

Burns; Cytokines; Inflammation; Mortality

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BURN; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MALE; MORTALITY; SURVIVAL;

ADULT; AGED; ANTIGENS, CD; BIOLOGICAL MARKERS; BURNS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033976742     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(99)00137-0     Document Type: Article

References (18)

1. Marano M.A., Fong Y., Moldawer L.L, et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol. Obstet. 170:1990;32.
2. Ueyama M., Maruyama, Osame M., et al. Marked increase in plasma interleukin-6 in burn patients. J. Lab. Clin. Med. 120:1992;693.
3. Drost A.C., Burleson D.G., Cioffi W.G., et al. Plasma cytokines after thermal injury and their relationship to infection. Ann. Surg. 218:1992;74.
4. Endo S., Inada K., Yamada Y., et al. Plasma tumor necrosis factor-α (TNF-α) levels in patients with burns. Burns. 19:1993;124.
5. Yamada Y., Endo Y., Inada K. Plasma cytokine levels in patients with severe burn injury: with reference to the relationship between infection and prognosis. Burns. 22:1996;587.
6. Heinricson B.E., Benjamin W.R., Vogel S.N. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect. Immun. 58:1990;2429.
7. Kasai T., Inada K., Takakuwa T., et al. Antiinflammatory cytokine levels in patients with septic shock. Res. Commun. Mol. Pathol. Pharmacol. 98:1997;34.
8. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644/Crit. Care Med. 1992;20:864.
9. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644/Crit. Care Med. 1992;20:864.
10. Endo S., Inada K., Yamada Y., et al. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns. J. Med. 27:1996;57.
11. Brockhaus M., Schoenfeld H.J., Sclaeger E.J., et al. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. 87:1990;3127.
12. Adolf G.R., Apfler I. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids. J. Immunol. Meth. 143:1991;127.
13. Sato N., Kimura Y., Ikeda K., et al. Production of antiinflammatory cytokines after esophageal operation. Faist E. The immune consequences of trauma, shock and sepsis. 1997;167 Monduzzi Editore.
14. Holzheimer R.G., Gross J., Schein M. Pro and antiinflammatory cytokine-response in abdominal aortic aneurysm repair: a clinical model of ischemia-reperfusion. Shock. 11:1999;305.
15. Kaufman P., Tilz G.P., Luege A., et al. Elevated plasma levels of soluble tumor necrosis factor receptor (STNFRp60) reflect severity of acute pancreatitis. Intensive Care Med. 23:1997;841.
16. Pfeffer K., Matsuyama T., Kundig, et al. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet sucamb to L. monocytogenes infection. Cell. 73:1993;457.
17. Rothe J., Lesslauer W., Lotscher H., et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364:1993;798.
18. Girardin R., Roux-Lombard P., Grau G.E., et al. Imbalance between tumor necrosis factor-α and soluble TNF receptor combination in severe meningococcaemia. Immunology. 76:1992;20.